Browsing Tag
Massachusetts
120 posts
Jury weighs murder or lack of criminal responsibility in closely watched Lindsay Clancy trial
Lindsay Clancy’s murder trial reaches the jury as prosecutors and defense clash over postpartum psychosis, intent and criminal responsibility.
Massachusetts manhunt intensifies for Karen Solomon after veteran Worcester police officer’s death
Massachusetts authorities intensify the search for Karen Solomon as an arrest warrant follows the death of veteran Worcester officer Kurt Solomon.
CPS Technologies (NASDAQ: CPSH) doubles footprint with 80,000sft Massachusetts lease
CPS Technologies has signed a long-term lease for an 80,000-square-foot facility in Attleboro, roughly doubling its footprint as defence, energy and advanced-materials programmes move toward commercialization.
Sleep apnoea biotech Apnimed (APMD) climbs in Nasdaq debut after upsized offering
Apnimed raised $192M in an upsized Nasdaq IPO to fund oxnimbi's launch, with the FDA's February 28, 2027 decision on the first oral OSA pill now the pivot.
Corbus Pharmaceuticals (NASDAQ: CRBP) lands FDA clearance for TEMPO-1 as CRB-701 enters Phase 3
CRB-701 delivered a 42.9% ORR in 2L OPSCC. Corbus Pharmaceuticals must now reproduce it in a 250-patient TEMPO-1 trial that starts enrolling in September.
Eastern Bankshares (EBC) posts record operating income of $106.5m, lifts wealth assets to $11.5bn
Eastern Bankshares posts record $106.5M operating income and a 5% buyback authorization, but CRE payoffs and rising deposit costs test the growth thesis.
MAPFRE bets $1.54bn on New England insurance scale, but will the numbers work?
MAPFRE S.A. is offering Safety Insurance Group shareholders $105 per share in cash, creating a larger regional insurer while testing whether scale and synergies can justify a 44% acquisition premium.
Is Parabilis Medicines’ $670m Nasdaq IPO a biotech comeback signal or a high-risk oncology wager?
Find out how Parabilis Medicines’ upsized Nasdaq IPO reshapes biotech financing, Regeneron validation and investor appetite for Helicon platform drugs now.
US offshore wind lawsuit turns Trump energy policy into a high-stakes federalism fight
Trump’s fossil fuel pivot now faces a state lawsuit. Offshore wind has become a test of federal power, clean energy planning and investor risk.
UnitedHealth (UNH) unit sued by Massachusetts over alleged $100m MassHealth upcoding scheme
Massachusetts is suing a UnitedHealth unit over an alleged $100M MassHealth upcoding scheme. UNH calls it meritless, but the precedent risk is the real story.